Social Media Ideas for Lly

Here’s What the Street Thinks About Eli Lilly and Company (LLY)

How to Buy Eli Lilly Stock (LLY)

Pharmaceuticals and the stock market may seem like two completely different worlds to beginner investors, but Eli Lilly and Company proves otherwise. Its stock has delivered exc...

Here’s What the Street is Saying About Eli Lilly and Company (LLY)

Eli Lilly stock extends rally as ACHIEVE-3 trial boosts Foundayo outlook

3 Reasons to Buy Eli Lilly Stock

Despite several setbacks over the past year, the drugmaker marches on.

Eli Lilly Just Got a Huge Vote of Confidence From Morgan Stanley -- and It's All About Mounjaro

The efficacy of Eli Lilly's new, still-in-development GLP-1 drug is gaining attention, but don't forget its older GLP-1 drugs just yet.

Eli Lilly (LLY) – Among the 10 Safe Stocks to Buy for the Long Term in 2026

Why Eli Lilly Gained 7% On Friday

Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?

Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.

Is Eli Lilly Stock an Undervalued Stock to Buy?

Consumer demand for Eli Lilly's weight-loss treatments continues to rise.

Why Eli Lilly Stock Climbed to a New All-Time High Today

The pharma giant is well-positioned to lead the $200 billion global obesity treatment market.

<![CDATA[AlzeCure Enters $1 Billion Collaboration and Out-Licensing Agreement with Eli Lilly ]]>

Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are Missing

Eli Lilly just announced a trio of acquisitions that will allow it to build a new business focused on infectious diseases.

Is It Too Late to Buy Eli Lilly?

The stock has soared 400% in recent years.

Lyell Immunopharma: Undervalued Ahead Of A Major CAR-T Inflection

Record Numbers of Americans Are on GLP-1 Drugs. That's Great News for This Stock.

Eli Lilly makes the best-selling GLP-1 drug, and sales are accelerating.

Is Eli Lilly and Company (LLY) Among the Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds?

Lilly moves deeper into Alzheimer’s research with AlzeCure licensing deal

Eli Lilly has signed a heavily backloaded agreement to license a gamma-secretase modulator treatment for Alzheimer's disease from AlzeCure Pharma for up to $1 billion biobucks.

May 26 2026 - Lilly to acquire three vaccine developers for nearly $4 billion

May 26 2026 - Lilly to acquire three vaccine developers for nearly $4 billion admin Tue, 05/26/2026 - 11:55 Lilly keeps pushing forward with deals and pipeline mome...

Lilly buys non-opioid pain drugmaker 4E

It’s the latest in a string of deals for Lilly, which has sunk more than $18 billion into acquisitions over the past few years.

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio]]>

AbbVie vs Eli Lilly: 1 Is Clearly the Better Dividend Stock to Buy and Hold for the Next 10 Years

<![CDATA[Eli Lilly Enters Three Separate Acquisitions Totaling $3.83 Billion ]]>

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration]]>